How Long Do Thread Lifts Last? Absorption, Collagen Response & the Evidence

Medically reviewed by Sarah Bennett, Medical Aesthetic Educator · Reviewed against published literature, September 2026 · 9 min read

The honest answer to "how long does a thread lift last?" cannot be a single number, because the question conflates two separate biological events. The thread itself is absorbed by hydrolysis — that is chemistry with a fairly narrow range. The visible result, however, depends on a collagen remodeling cascade that begins after the thread starts dissolving, continues past full absorption, and varies substantially between individuals. This article separates those two timelines using published data, explains the mechanism behind the difference, and outlines what a practitioner can and cannot do to influence result duration.

Why Results Outlast the Thread: The Remodeling Mechanism

A thread lift works in two phases. The first is mechanical: barbed or screw designs physically engage tissue and reposition it — this is the immediate lift visible in the chair. The second is biological: the polymer's degradation products and the mechanical micro-trauma of placement trigger a wound-healing response around each thread channel. Fibroblasts migrate in, and collagen deposition begins along the thread axis.

Two details from the histology literature matter for any longevity discussion. First, increased collagen density has been measured in tissue after PDO thread placement, alongside elevated MMP-1 — the enzyme that remodels existing collagen — indicating that both synthesis and turnover are active, not just scar formation [4]. Second, this response is sustained, because the stimulus persists as long as the material is present. A thread absorbed in 6 months stops signaling at 6 months; a thread absorbed over 18 months keeps signaling for 18 months. That single difference — duration of the biological stimulus — explains most of the longevity gap between materials.

What the Published Data Actually Reports

PDO (polydioxanone)

• Absorption: the polymer undergoes hydrolytic degradation over roughly 6 months; this figure is consistent across manufacturer documentation and comparative studies [2].
• Clinical outcomes: a randomized comparative clinical study of PDO thread treatment reported that after four months, 90% of treated subjects described improved skin texture and brightness, with only mild, transient swelling and no major complications [3]. A separate review characterizes PDO threads as effective for rejuvenation with a favorable complication profile [1].
• Notably: the same randomized study examined whether placing more threads produced better results — the authors found outcomes were not simply dose-dependent, a finding that directly challenges the "more is better" assumption common in commercial marketing [3].

PCL (polycaprolactone)

• Absorption: comparative efficacy data describe absorption over 1–1.5 years, versus 6 months for PDO [2].
• Clinical outcomes: in the same comparative study, the PCL group showed significant increases in skin-quality parameters as early as 4 weeks, both PCL groups outperformed comparator groups at 8 weeks, and wrinkle depth decreased by approximately 20% at week 8 [2].
• Interpretation: PCL's advantage is not "stronger" collagen stimulation at any single moment — it is longer stimulation. The practical consequence is a maintained-result window commonly reported at 18–24 months, roughly two to three times that of PDO.

PLLA (poly-L-lactic acid)

• Absorption: 12–24 months, the slowest of the three.
• Clinical outcomes: published evidence on PLLA threads is thinner than for PDO and PCL; the material's mechanism (progressive collagen remodeling with minimal mechanical lift) is well characterized from the broader poly-L-lactic acid literature, and result durations of 12–24 months are consistent with that mechanism.
• Practice implication: because there is no immediate lift, PLLA is the material where expectation-setting failure causes the most patient dissatisfaction — the result timeline must be explained before the procedure.

What this evidence does not tell you

Two gaps are worth stating plainly. Study designs are not standardized across the thread literature — gauge, thread count, area and outcome measures differ between publications, so cross-study comparisons are approximate rather than exact. And most published cohorts are small. The numbers above are the best available anchors, not universal guarantees.

Absorption vs Result: The Practitioner's Reference Table

What Actually Changes Longevity: Six Practitioner-Controllable Factors

Published duration ranges describe populations; individual results are set by factors a practitioner can assess and, in part, control.

1. Thread type within the material. Lifting designs (cog, molding) retain mechanical anchoring and therefore hold longer than collagen-only mono placements in the same patient. Choosing "mono vs cog" is the first longevity decision.
2. Treatment area. High-mobility zones — nasolabial folds, marionette lines, the lateral brow — experience more mechanical stress and shorter clinical duration. Documenting area-specific expectations is standard practice in clinics that track outcomes.
3. Placement depth and vector. A cog thread placed too superficially loses engagement within weeks; depth and vector errors are among the most cited technical causes of early result loss in the complications literature [6].
4. Thread count and distribution. The randomized data caution against the "more is better" heuristic [3], but genuine under-treatment (too few threads for the area) under-delivers. Density should be planned per area, not maximized.
5. Individual collagen response. Age, skin quality, hormonal status and lifestyle (sun exposure, smoking, sleep) modulate collagen synthesis capacity. This is the largest uncontrollable variable — and the reason reputable clinics quote ranges, not promises.
6. Material choice. The same protocol executed in PDO, PCL or PLLA produces progressively longer result windows. Material selection is the multiplier on every factor above.

The maintenance schedule that follows

• PDO: reassess at 6 months; touch-up at 9–12 months (6–9 months in high-mobility zones).
• PCL: reassess at 12 months; touch-up at 18–24 months.
• PLLA: reassess at 6 months; top-up at 12–18 months if remodeling is the goal.

How Practitioners Should Communicate Longevity

The consulting conversation determines satisfaction more than any brochure number. A clinically grounded script has three beats:

1. Separate the timelines explicitly. "The thread dissolves in about six months; the result continues because your skin's own collagen takes over — most patients see the lift hold for 6–12 months."
2. Give a range, then the determinants. Quote the published range, then state the two or three factors specific to this patient (area, skin quality, thread type planned).
3. Schedule the reassessment visit. A booked 6-month review (PDO) or 12-month review (PCL) converts an abstract "duration" claim into a documented outcome — and is the most credible basis for the clinic's own published results.

For clinics building a before-and-after library, standardize photography windows per material: PDO at baseline, 1 and 3 months; PCL at baseline, 3 and 9–12 months; PLLA at baseline, 3 and 6 months. Consistent intervals make results comparable — and comparable results are the only E-E-A-T asset that matters for patient trust.

Frequently Asked Questions

Does the thread have to dissolve before the result fades? No — and this is the most common misunderstanding. The result peaks while the thread is still present and fades gradually as the collagen response subsides, which is why the maintained window extends past the absorption date.

Why do different sources quote different durations for the same material? Because duration is reported for different endpoints (lift retention, collagen quality, patient satisfaction) and different cohorts. The ranges here reflect published data; individual results vary with area, technique and biology.

Can results be extended beyond the typical window? Partly. Selecting a longer-duration material (PCL over PDO), optimizing depth and vector, and maintaining skin quality between sessions (sun protection, consistent skincare) are the evidence-aligned levers. No protocol can override poor candidacy.

Is "lasts two years" a realistic claim for PCL? 18–24 months of maintained results is consistent with the published absorption data for PCL [2]. Clinics should still quote a range and document outcomes rather than promise a fixed date.

Do more threads mean longer-lasting results? The randomized comparative data do not support a simple dose-response relationship [3]. Correct planning per area matters more than maximizing thread count.

Next Steps

Longevity is a material decision, a technique decision and a communication decision in that order. For the full side-by-side material comparison, see PDO vs PCL vs PLLA Threads: Differences, Longevity & How to Choose, or the Thread Lifting FAQ for candidacy and aftercare checklists.

Explore the PDO Threads Collection, PCL Threads Collection and PLLA Threads Collection — CE-Marked, medical-grade threads for clinics that quote durations they can document.

For clinics and distributors, wholesale pricing and OEM options are available — contact our team for bulk inquiries.

---

References

1. Using PDO threads: A scarcely studied rejuvenation technique. Journal of Cosmetic Dermatology (Wiley) — PDO efficacy and complication profile.
2. Efficacy study of the new polycaprolactone thread compared with other absorbable threads. Journal of Cosmetic Dermatology — absorption 1–1.5 years vs PDO 6 months; significant skin-quality improvement from week 4; ~20% wrinkle reduction at week 8.
3. Is more always better? A randomized comparative clinical study on PDO thread outcomes. PMC — 90% improved texture/brightness at 4 months; no major complications; outcome not simply dose-dependent.
4. The efficacy of the absorbable polydioxanone (PDO) thread lift in lower-face marionette line rejuvenation — collagen density and MMP-1 findings.
5. Practitioner-published outcome data on PDO/PCL result duration and maintenance intervals (clinical practice literature).
6. Polydioxanone thread lift complications — technical risk factor analysis (HMP Global, The Dermatologist).

Editorial note on review process: this article was drafted from the sources listed, with claims about absorption and clinical outcomes traced to the cited publications; durations outside the cited ranges are described as practice-based estimates. The article is reviewed and updated annually, or earlier when new comparative data are published.

Sarah Bennett, Medical Aesthetic Educator
Sarah Bennett is a medical aesthetic educator with over 12 years of experience in non-surgical procedures, specializing in thread lifting and collagen biostimulation. She has trained practitioners across North America and Europe, and writes the clinical education content for Auro Threads, in collaboration with the Auro Medical Education Team. All articles are reviewed against current clinical literature and intended for licensed medical professionals.